Member Info for deepjoy

moniman.. In a recent interveiw Cathal stated that Jupiter had been reassured by his business plan and undertaken not to reduce thir holding until his target of december for sale... i have no reason to doubt it if they picked them up on the cheap..

its called a bear market kop... quality companies simple strategy hold. True value will always win out in the end - months not minutes :)

and if i recall i thought they were willing to licence the vacinne for circa £50m which i am not sure would include royalties ...

Comek2 you stated ' However, you seem to overlook the fact they have a joint venture to develop the influenza vaccine into a universal one.' perhaps you will be kind enough to source the evidence that they have a JV to go to stage 3....? I don't think they do have one but, rather are willing to 'licence it' for others to try if they were approached . The one point Cathal did say firmly was that no capital would be risked on drug development by HVO ... so where is the evidence that has changed? happy to be proved wrong

The view that this has the potential to ten bag plus bagger is complete fantasy...Get real for gawds sake!! it is a clinical services company not a drug development company and basic levels of research will tell you how the company has been configured to be such. Take this ramping talk elsewhere any sensible investor knows that if an offer was made for 18p a share it would be sold tomorrow but that is th ticket price once it is profitable as Cathal has stated.....

is the one thing I do not appreciate about this share. The use of delayed reporting on such little volume doesnt inspire confidence and even with 2x250k buys late reported you can see how the bid is dropped on no volume to fill orders... Hence there is no transparency and for me; no trust in live pricing. it is a pain in the @£se!!!

spot on andinio !! :)

Jim... According to Cathal in a recent interview he let slip that jupiter had sold out two weeks ago after the firms borker advised them of that ...Also that invesco had 'committed' to given him 12 months to prove the concept so all things being equal this is PIs driving SP movements at the moment...

cheers for that Shandy.....nice he is confident but not overconfident and ramping :)

PS... the MMs are desperately trying to keep the SP at current levels with delayed reporting of small trades. I have no problem with that :)

Jim.. The trade patterns dont indicate IIs selling down and the late reported trades are far less than last week. I think we have impatient or panicky small holders hedging or selling down atm. The problem in my mind is that it will need to take contract news to get the SP moving. Too many filler RNSs atm and HVO transferees have heard it all before; contract announcments will instil confidence that there is the demand for services. I beleive Cathal stated the first announcement may be delayed by a week or two but my investment case for this company is that the Convic 19 outbreak will highlight to pharma majors how much they need to expand there research services and in that sense, this company is a very very attractive proposition when it hits profit this year. i dont see a re-rate that others do as fast but with a ticket price on any future sale of circa 18p per share I have my conviction play for 2020 albeit i find myself way over exposed.. GLA

Shady.. thanks for taking the time to give feedback on last night..I to am very comfortable with my investment. So much so it is one of two share i own now outside funds and my biggest by a country mile. People expecting instant uplift and results from a company strategy arent investors in my book they are traders.. If Cathal has sucha large position and IIs have backed this company at a premium raise three times now, them I am for sure. Months not days is the way to make money with this share. GLA

moni... it takes time to synergise the businesses and secure contracts, this wont happen overnight and id rather no RNS' for a while that fillers of the past week or so. i thnk it is fair to say the demand will undoubtedly be there for clinical services so i am happy to look towards months rather than days, especially as they have 7m funding and little downside risk atm... Keep the faith :)

The way the trades are being late reported here suggests (to me at least) that there are orders both sides of the book looking to get filled with MMs posting small trades to keep the price in range... Its holding up pretty well to be honest and if and when "contract" news lands it will re-rate significantly. positive for me :)

...more perky now :)

I agree Bronx a filler RNS again .....pointless

The thing that really gets my goat with this share atm is the clear strategy of delayed reporting on very low volumes. Now, on the plus side it enables market makers to keep the SP in a steady range however, it discourages buyers when it is impossible for them to gauge true volumes / movements. wish they would open the book and let the churn continue more transparently..!

I wish you lot would do some research... the hvo unit is a medical research unit to develop staged vaccine develpment not treat full blown disease....

I can buy 50k at 6.138 now so some in the pot still to shift and i suspect it is selling at any price...late reported no doubt

someone loading up nicely 10x50k tranches at 6.14 ......save paying higher i suppose ...